These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38919490)
21. Hormonal diagnosis of GH hypersecretory states. Grottoli S; Gasco V; Ragazzoni F; Ghigo E J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657 [TBL] [Abstract][Full Text] [Related]
22. Acromegaly. Scacchi M; Cavagnini F Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948 [TBL] [Abstract][Full Text] [Related]
23. Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? De Menis E; Tulipano G; Villa S; Billeci D; Bonfanti C; Pollara P; Pauletto P; Giustina A J Endocrinol Invest; 2003 Apr; 26(4):359-63. PubMed ID: 12841545 [TBL] [Abstract][Full Text] [Related]
24. "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era. Butz LB; Sullivan SE; Chandler WF; Barkan AL Pituitary; 2016 Dec; 19(6):547-551. PubMed ID: 27497970 [TBL] [Abstract][Full Text] [Related]
25. [Acromegaly and pregnancy: report of six new cases]. Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359 [TBL] [Abstract][Full Text] [Related]
34. A challenging TSH/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review. Yoon JH; Choi W; Park JY; Hong AR; Kim SS; Kim HK; Kang HC BMC Endocr Disord; 2021 Aug; 21(1):177. PubMed ID: 34461869 [TBL] [Abstract][Full Text] [Related]
35. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288 [TBL] [Abstract][Full Text] [Related]
36. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395 [TBL] [Abstract][Full Text] [Related]
37. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma. Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929 [TBL] [Abstract][Full Text] [Related]
38. Association of acromegaly and meningiomas. Bunick EM; Mills LC; Rose LI JAMA; 1978 Sep; 240(12):1267-8. PubMed ID: 682310 [No Abstract] [Full Text] [Related]
39. Pathology of acromegaly. Horvath E; Kovacs K Neuroendocrinology; 2006; 83(3-4):161-5. PubMed ID: 17047379 [TBL] [Abstract][Full Text] [Related]
40. Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis. Mondin A; Manara R; Voltan G; Tizianel I; Denaro L; Ferrari M; Barbot M; Scaroni C; Ceccato F Front Endocrinol (Lausanne); 2022; 13():935759. PubMed ID: 35846311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]